An explanation for these improvements in T cell function is the finding that metformin treatment of mice with B16 melanoma tumors inhibited tumor cell metabolism (both oxidative phosphorylation and glycolysis) but concurrently enhanced endogenous CD8+ T cell metabolism (oxidative phosphorylation) and cytokine production (53). Here, CD8A is linked to neoplasm.